December 1, 2025
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers
November 7, 2025
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
November 6, 2025
Seer Reports Third Quarter 2025 Financial Results
October 29, 2025
Seer to Participate in Upcoming November Investor Conferences
October 16, 2025
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 10, 2025
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
September 2, 2025
Seer Appoints Isaac Ro to its Board of Directors
August 26, 2025
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 6, 2025
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
July 31, 2025
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
Pagination